Maynard Um
-
-
-
-
-
-
-
Tonix Pharmaceuticals presents fibromyalgia opioid use data at medical meeting
-
-
-
-
-
-
-
Tonix Pharma (TNXP) Misses Q4 EPS by 79c
-
-
-
-
-
-
-
Tonix presents fibromyalgia drug data at rheumatology conference
-
-
-
-
-
-
-
Tonix Pharma (TNXP) halted, news pending
-
-
-
-
-
-
-
Tonix Pharma (TNXP) Files $500M Mixed Shelf
-
-
-
-
-
-
-
New to The Street Show #639 Premieres Nationwide on Bloomberg Television, March 29 at 6:30 PM EST Featuring BioVie, Roadzen, Tonix Pharma, and eXoZymes Inc.
-
-
-
-
-
-
-
Tonix Pharma (TNXP) Announces Positive Topline Results from Phase 1 Trial for TNX-1500, a Next Generation anti-CD40L mAb Candidate for Prevention of Kidney Transplant Rejection and Treatment of Autoim
-
420,356 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

